Department of Internal Medicine, Faculty of Medicine, Chiang Mai University
Chiang Mai, 50200, Thailand
NCT Number: NCT01363869
Green tea has been extensively investigated for several potential health benefits. Previous studies have suggested that green tea may lower serum uric acid level in human. The purpose of this study is to investigate uric-lowering properties of green tea in healthy individuals.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chiang Mai, 50200, Thailand
Elevated serum uric acid is related to the risk of development of gout, the most common inflammatory arthritis in men. Allopurinol, a xanthine oxidase inhibitor, is one of the uric-lowering agents commonly used in patients suffering from recurrent and chronic gout. Nevertheless, its use is limited by adverse effects and serious allergic reaction in some patients.
Green tea is one of the most frequently consumed beverages, particularly in Japan. Green tea contains high level of catechins, in which Epigallocatechin gallate (EGCG) is the most abundant compound among other types of catechins. Antioxidant effect contributes to various potential health benefits of green tea. Several in-vitro studies have found that green tea inhibits xanthine oxidase activity and subsequently decreases reactive oxygen species (ROS) and uric acid production. We therefore would like to investigate the hypouricemic effects of green tea.
The study consists of three periods with a total duration of four weeks. The first week is the control period. The following two weeks is the interventional period and the last week is the follow up period. Thirty healthy participants will be randomly assigned into three experimental groups, receiving 2 gm/day, 4 gm/day and 6 gm/day (in capsule, two times after meal) of green tea extract during interventional period. Blood and urine samples will be taken at the beginning and at the end of each study period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 2 grams per day.
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 4 grams per day.
Green tea extracts capsule (1 gm per capsule), taken after meal, twice daily for 14 days.
Total dosage is 6 grams per day.
Time frame: 4 weeks (prior to, immediately after and 7 days after intervention)
Time frame: 4 weeks (prior to, immediately after and 7 days after intervention)
Time frame: 4 weeks (prior to, immediately after and 7 days after intervention)
Time frame: 1 week (immediately after and 7 days after intervention)
Measurements of serum level of epigallocatechin gallate (EGCG)
Time frame: 4 week (prior to, immediately after and 7 days after intervention)
Adverse events during 4-week study
Chiang Mai University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06056570
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Clearwater, Florida, United States
View Trial DetailsNCT06439602
Arthritis, Arthritis, Gouty
Foley, Alabama, United States
View Trial DetailsNCT03934099
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Birmingham, Alabama, United States
View Trial DetailsNCT05586958
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Birmingham, Alabama, United States
View Trial Details